Peter Kirk
Impact in
- Immunology top 10%
- Galectins and Cancer Biology
- Immunotherapy and Immune Responses
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Oncology 8
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 3
-
- Immunotherapy and Immune Responses 4
- Galectins and Cancer Biology 2
- Biosimilars and Bioanalytical Methods 2
- Immune Cell Function and Interaction 2
- Co-authors
- A. Neil Barclay (3 shared papers)Marieangela C. Wilson (2 shared papers)Catherine Heddle (2 shared papers)Andrew P. Halestrap (1 shared paper)Thomas Hassard (1 shared paper)B. Joyce Davison (1 shared paper)Lesley F. Degner (1 shared paper)J. Fernando Bazán (1 shared paper)
- Journals
- Journal of Biomedical Materials Research (1 paper)Journal of Clinical Oncology (1 paper)The EMBO Journal (1 paper)Cancer Research (1 paper)Immunity (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Peter Kirk
14 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Immunology 281
- Oncology 280
- Cancer Research 152
- Molecular Biology 615
- Renewable Energy, Sustainability and the Environment 132
Countries citing papers authored by Peter Kirk
This map shows the geographic impact of Peter Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kirk more than expected).
Fields of papers citing papers by Peter Kirk
This network shows the impact of papers produced by Peter Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kirk. The network helps show where Peter Kirk may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Kirk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression Hit paper breakdown → | 2000 | 576 |
| 2 | 2010 | 191 | |
| 3 | 1999 | 119 | |
| 4 | 2017 | 111 | |
| 5 | 2003 | 48 | |
| 6 | 2005 | 40 | |
| 7 | 2024 | 10 | |
| 8 | 2023 | 9 | |
| 9 | 2017 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2025 | 4 | |
| 12 | Co-localization of immunoglobulin superfamily member CD147 with a monocarboxylate transporter (MCT1) | 1999 | 2 |
| 13 | 2024 | 1 | |
| 14 | 1999 | 1 |
About Peter Kirk
Peter Kirk is a scholar working on Oncology, Immunology, Molecular Biology, Immunology and Allergy and Surgery, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (4 papers), Signaling Pathways in Disease (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Galectins and Cancer Biology (2 papers), Cell Adhesion Molecules Research (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Immunology (281 citations), Oncology (280 citations), Cancer Research (152 citations), Molecular Biology (615 citations) and Renewable Energy, Sustainability and the Environment (132 citations). Peter Kirk has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include A. Neil Barclay, Marieangela C. Wilson, Catherine Heddle, Andrew P. Halestrap, Thomas Hassard, B. Joyce Davison, Lesley F. Degner, J. Fernando Bazán, Philip A. Lee and Craig A. Hokanson. Their work appears in journals such as Journal of Biomedical Materials Research, Journal of Clinical Oncology, The EMBO Journal, Cancer Research and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.